UpLyft®, the world’s first seated self-transfer system, allows users to transfer between bed and wheelchair without any caregiver assistance or physical force
SAN DIEGO, Calif. — Pathway Medtech, a leading medical device manufacturer, is proud to announce that it has won the prestigious Core77 Health & Wellness Design Award for its design work on the UpLyft®, the world’s first seated self-transfer system of its kind. By doing so, the San Diego-based business also beat out many larger competitors. Pathway Medtech also received a notable in the Commercial Equipment category. Pathway Medtech provided extensive design, engineering, regulatory, and manufacturing support for this project.
This recognition from the global industrial design publication Core77 is a testament to Pathway Medtech’s unwavering commitment to excellence, innovation, and exceptional service in the medical device industry.
The Core77 Health & Wellness Design Award is one of the most coveted accolades in industrial design, and it is awarded annually to companies that have demonstrated remarkable achievements and made significant contributions to their field. Pathway Medtech was chosen to design and manufacture the UpLyft® due to its dedication to exceeding customer expectations, fostering industry growth, and pushing the boundaries of medical device manufacturing.
“UpLyft was a special project. This product has the potential to help many people, and at Pathway we have worked for years to hone our skills and bring amazing technologies like the UpLyft to market. It is particularly special to be recognized for such an impactful project,” states Jonas Cochran, lead designer and COO at Pathway Medtech.
Pathway Medtech is an ISO 13485:2016 certified facility with class 7 cleanrooms, providing scalable, cost-effective contract manufacturing from small to large-volume production. The company adheres to FDA regulations that address applicability and good manufacturing practices. This ensures that products brought to market with its help are both safe and effective under the Federal Food, Drug, and Cosmetic Act.
“Pathway Medtech has grown to become a go-to provider for medical device manufacturing,” says Craig Misrach, President & CEO of UpLyft. “Their groundbreaking solutions, cutting-edge technologies, and exceptional customer-centric approach have set them apart as industry pioneers and thought leaders. We are happy to have worked with them on this project and look forward to working with them on our next innovation. This award not only recognizes our past accomplishments but also serves as a catalyst for future endeavors and reinforces our joint commitment to driving growth and success.”
Founded in 2011, the Core77 Design Awards champions the principles of inclusivity, innovation, and excellence. Recognizing the broad spectrum nature of the design field, the awards program offers 14 distinct categories for entry, each further broken into dedicated sections for professionals and students. The Health and Wellness portion is only open to professionals.
About Pathway Medtech
Based in Southern California, Pathway Medtech is on a mission to positively impact the evolution of health care through the development and production of innovative medical technologies. Backed by industry-leading capabilities and resources, we help entrepreneurs and inventors design, validate, and manufacture MedTech products that aim to improve health care for all. To learn more about Pathway Medtech, visit pathwaymedtech.com.
About UpLyft
UpLyft addresses the critical need for an innovative method to empower people with mobility limitations to safely and efficiently self-transfer from bed to wheelchair and vice versa. For consumers at home, UpLyft restores independence to people with mobility challenges, improving their quality of life. In institutional settings, UpLyft protects healthcare workers from encountering patient lifting injuries, avoiding costly workers’ compensation claims. For additional information on UpLyft, please visit the company’s website at www.myuplyft.com.